Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheyne Kurokawa

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Ticks and Tick-Borne Diseases|January 12, 2020
Ixodes scapularis saliva components that elicit responses associated with acquired tick-resistanceSukanya Narasimhan, Cheyne Kurokawa, Husrev Diktas, et al.
Molecular Therapy. Oncology|April 10, 2024
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12Cheyne Kurokawa, Sonia Agrawal, Abhisek Mitra, et al.
Journal of the National Cancer Institute|May 23, 2018
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic VirotherapyCheyne Kurokawa, Ianko D Iankov, S Keith Anderson, et al.
NPJ Vaccines|December 13, 2025
Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2Jason P Laliberte, Yingyun Cai, Tara Kenny, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Ticks and Tick-Borne Diseases|January 12, 2020
Ixodes scapularis saliva components that elicit responses associated with acquired tick-resistanceSukanya Narasimhan, Cheyne Kurokawa, Husrev Diktas, et al.
Molecular Therapy. Oncology|April 10, 2024
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12Cheyne Kurokawa, Sonia Agrawal, Abhisek Mitra, et al.
Journal of the National Cancer Institute|May 23, 2018
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic VirotherapyCheyne Kurokawa, Ianko D Iankov, S Keith Anderson, et al.
NPJ Vaccines|December 13, 2025
Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2Jason P Laliberte, Yingyun Cai, Tara Kenny, et al.
Pageof 2